168 related articles for article (PubMed ID: 14562054)
1. Increased expression and no mutation of the Flap endonuclease (FEN1) gene in human lung cancer.
Sato M; Girard L; Sekine I; Sunaga N; Ramirez RD; Kamibayashi C; Minna JD
Oncogene; 2003 Oct; 22(46):7243-6. PubMed ID: 14562054
[TBL] [Abstract][Full Text] [Related]
2. FEN1 promotes tumor progression and confers cisplatin resistance in non-small-cell lung cancer.
He L; Luo L; Zhu H; Yang H; Zhang Y; Wu H; Sun H; Jiang F; Kathera CS; Liu L; Zhuang Z; Chen H; Pan F; Hu Z; Zhang J; Guo Z
Mol Oncol; 2017 Jun; 11(6):640-654. PubMed ID: 28371273
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA expression distinguishes SCLC from NSCLC lung tumor cells and suggests a possible pathological relationship between SCLCs and NSCLCs.
Du L; Schageman JJ; Irnov ; Girard L; Hammond SM; Minna JD; Gazdar AF; Pertsemlidis A
J Exp Clin Cancer Res; 2010 Jun; 29(1):75. PubMed ID: 20624269
[TBL] [Abstract][Full Text] [Related]
4. Molecular genetics of small cell lung carcinoma.
Wistuba II; Gazdar AF; Minna JD
Semin Oncol; 2001 Apr; 28(2 Suppl 4):3-13. PubMed ID: 11479891
[TBL] [Abstract][Full Text] [Related]
5. The FEN1 L209P mutation interferes with long-patch base excision repair and induces cellular transformation.
Sun H; He L; Wu H; Pan F; Wu X; Zhao J; Hu Z; Sekhar C; Li H; Zheng L; Chen H; Shen BH; Guo Z
Oncogene; 2017 Jan; 36(2):194-207. PubMed ID: 27270424
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of Flap Endonuclease 1 Correlates with Enhanced Proliferation and Poor Prognosis of Non-Small-Cell Lung Cancer.
Zhang K; Keymeulen S; Nelson R; Tong TR; Yuan YC; Yun X; Liu Z; Lopez J; Raz DJ; Kim JY
Am J Pathol; 2018 Jan; 188(1):242-251. PubMed ID: 29037854
[TBL] [Abstract][Full Text] [Related]
7. Mutations in the p16INK4/MTS1/CDKN2, p15INK4B/MTS2, and p18 genes in primary and metastatic lung cancer.
Okamoto A; Hussain SP; Hagiwara K; Spillare EA; Rusin MR; Demetrick DJ; Serrano M; Hannon GJ; Shiseki M; Zariwala M
Cancer Res; 1995 Apr; 55(7):1448-51. PubMed ID: 7882351
[TBL] [Abstract][Full Text] [Related]
8. PRMT1 is critical to FEN1 expression and drug resistance in lung cancer cells.
He L; Hu Z; Sun Y; Zhang M; Zhu H; Jiang L; Zhang Q; Mu D; Zhang J; Gu L; Yang Y; Pan FY; Jia S; Guo Z
DNA Repair (Amst); 2020 Nov; 95():102953. PubMed ID: 32861926
[TBL] [Abstract][Full Text] [Related]
9. High risk of benzo[α]pyrene-induced lung cancer in E160D FEN1 mutant mice.
Wu Z; Lin Y; Xu H; Dai H; Zhou M; Tsao S; Zheng L; Shen B
Mutat Res; 2012 Mar; 731(1-2):85-91. PubMed ID: 22155171
[TBL] [Abstract][Full Text] [Related]
10. Mutation analysis of the PTEN/MMAC1 gene in lung cancer.
Forgacs E; Biesterveld EJ; Sekido Y; Fong K; Muneer S; Wistuba II; Milchgrub S; Brezinschek R; Virmani A; Gazdar AF; Minna JD
Oncogene; 1998 Sep; 17(12):1557-65. PubMed ID: 9794233
[TBL] [Abstract][Full Text] [Related]
11. Small molecule inhibitors uncover synthetic genetic interactions of human flap endonuclease 1 (FEN1) with DNA damage response genes.
Ward TA; McHugh PJ; Durant ST
PLoS One; 2017; 12(6):e0179278. PubMed ID: 28628639
[TBL] [Abstract][Full Text] [Related]
12. Single nucleotide polymorphism analyses of the human proliferating cell nuclear antigen (pCNA) and flap endonuclease (FEN1) genes.
Ma X; Jin Q; Försti A; Hemminki K; Kumar R
Int J Cancer; 2000 Dec; 88(6):938-42. PubMed ID: 11093818
[TBL] [Abstract][Full Text] [Related]
13. Different roles for caveolin-1 in the development of non-small cell lung cancer versus small cell lung cancer.
Sunaga N; Miyajima K; Suzuki M; Sato M; White MA; Ramirez RD; Shay JW; Gazdar AF; Minna JD
Cancer Res; 2004 Jun; 64(12):4277-85. PubMed ID: 15205342
[TBL] [Abstract][Full Text] [Related]
14. Flap endonuclease 1 is a promising candidate biomarker in gastric cancer and is involved in cell proliferation and apoptosis.
Wang K; Xie C; Chen D
Int J Mol Med; 2014 May; 33(5):1268-74. PubMed ID: 24590400
[TBL] [Abstract][Full Text] [Related]
15. Chemical-induced cancer incidence and underlying mechanisms in Fen1 mutant mice.
Xu H; Zheng L; Dai H; Zhou M; Hua Y; Shen B
Oncogene; 2011 Mar; 30(9):1072-81. PubMed ID: 20972458
[TBL] [Abstract][Full Text] [Related]
16. Differential inactivation of caspase-8 in lung cancers.
Shivapurkar N; Toyooka S; Eby MT; Huang CX; Sathyanarayana UG; Cunningham HT; Reddy JL; Brambilla E; Takahashi T; Minna JD; Chaudhary PM; Gazdar AF
Cancer Biol Ther; 2002; 1(1):65-9. PubMed ID: 12170765
[TBL] [Abstract][Full Text] [Related]
17. The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines.
Sato M; Horio Y; Sekido Y; Minna JD; Shimokata K; Hasegawa Y
Oncogene; 2002 Jul; 21(31):4822-9. PubMed ID: 12101420
[TBL] [Abstract][Full Text] [Related]
18. Overexpression and hypomethylation of flap endonuclease 1 gene in breast and other cancers.
Singh P; Yang M; Dai H; Yu D; Huang Q; Tan W; Kernstine KH; Lin D; Shen B
Mol Cancer Res; 2008 Nov; 6(11):1710-7. PubMed ID: 19010819
[TBL] [Abstract][Full Text] [Related]
19. Quantitative reverse transcription-polymerase chain reaction measurement of HASH1 (ASCL1), a marker for small cell lung carcinomas with neuroendocrine features.
Westerman BA; Neijenhuis S; Poutsma A; Steenbergen RD; Breuer RH; Egging M; van Wijk IJ; Oudejans CB
Clin Cancer Res; 2002 Apr; 8(4):1082-6. PubMed ID: 11948117
[TBL] [Abstract][Full Text] [Related]
20. FEN1 is overexpressed in testis, lung and brain tumors.
Nikolova T; Christmann M; Kaina B
Anticancer Res; 2009 Jul; 29(7):2453-9. PubMed ID: 19596913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
